Coronary Artery Disease — Effects of Espresso on Platelet Aggregability in Patients With Coronary Artery Disease
Citation(s)
Adriana Farah Coffee: Emerging Health Effects and Disease Prevention. Coffee Constituints. 2012. John Wiley & Sons, Inc. Published by Blackwell Publishing Ltd.
Andersen LF, Jacobs DR Jr, Carlsen MH, Blomhoff R Consumption of coffee is associated with reduced risk of death attributed to inflammatory and cardiovascular diseases in the Iowa Women's Health Study. Am J Clin Nutr. 2006 May;83(5):1039-46. doi: 10.1093/ajcn/83.5.1039.
Bak AA, van Vliet HH, Grobbee DE Coffee, caffeine and hemostasis: results from two randomized studies. Atherosclerosis. 1990 Aug;83(2-3):249-55. doi: 10.1016/0021-9150(90)90170-n.
Cavalcante et al Influência da Cafeína no Comportamento da Pressão Arterial e da Agregação Plaquetária. Arq Bras Cardiol, volume 75 (nº 2), 97-101, 2000
Dhand, N K., & Khatkar, M. S. (2014). Statulator: An online statistical calculator. Sample Size Calculator for Comparing Two Paired Means. Accessed 7 May 2019 at http://statulator.com/SampleSize/ss2PM.html
Diffenderfer MR, Schaefer EJ The composition and metabolism of large and small LDL. Curr Opin Lipidol. 2014 Jun;25(3):221-6. doi: 10.1097/MOL.0000000000000067.
Ding M, Bhupathiraju SN, Satija A, van Dam RM, Hu FB Long-term coffee consumption and risk of cardiovascular disease: a systematic review and a dose-response meta-analysis of prospective cohort studies. Circulation. 2014 Feb 11;129(6):643-59. doi: 10.1161/CIRCULATIONAHA.113.005925. Epub 2013 Nov 7.
Greenberg JA, Chow G, Ziegelstein RC Caffeinated coffee consumption, cardiovascular disease, and heart valve disease in the elderly (from the Framingham Study). Am J Cardiol. 2008 Dec 1;102(11):1502-8. doi: 10.1016/j.amjcard.2008.07.046. Epub 2008 Sep 11.
Happonen P, Voutilainen S, Salonen JT Coffee drinking is dose-dependently related to the risk of acute coronary events in middle-aged men. J Nutr. 2004 Sep;134(9):2381-6. doi: 10.1093/jn/134.9.2381.
Hattesen AL, Modrau IS, Nielsen DV, Hvas AM The absorption of aspirin is reduced after coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2019 Mar;157(3):1059-1068. doi: 10.1016/j.jtcvs.2018.08.088. Epub 2018 Sep 27.
Olas B, Brys M Effects of coffee, energy drinks and their components on hemostasis: The hypothetical mechanisms of their action. Food Chem Toxicol. 2019 May;127:31-41. doi: 10.1016/j.fct.2019.02.039. Epub 2019 Mar 4.
Rosner SA, Akesson A, Stampfer MJ, Wolk A Coffee consumption and risk of myocardial infarction among older Swedish women. Am J Epidemiol. 2007 Feb 1;165(3):288-93. doi: 10.1093/aje/kwk013. Epub 2006 Nov 16.
Wu JN, Ho SC, Zhou C, Ling WH, Chen WQ, Wang CL, Chen YM Coffee consumption and risk of coronary heart diseases: a meta-analysis of 21 prospective cohort studies. Int J Cardiol. 2009 Nov 12;137(3):216-25. doi: 10.1016/j.ijcard.2008.06.051. Epub 2008 Aug 15.
Evaluation of the Effect of Espresso on Platelet Aggregability in Patients With Coronary Artery Disease
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.